TB Nurse Case Management San Antonio, Texas April 9-11, 2013

Size: px
Start display at page:

Download "TB Nurse Case Management San Antonio, Texas April 9-11, 2013"

Transcription

1 TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB / Dose Counting Rachel Munoz, RN. TB Nurse Case Manager/Nurse Consultant Austin/Travis County Health Department April 10, 2013 Rachel Munoz, RN., has the following disclosures to make: No conflict of interests No relevant financial relationships with any commercial companies pertaining to this educational activity 1

2 Cure the individual patient Minimize risk of death and disability; and Reduce transmission of M. Tuberculosis to other persons Directly Observed Therapy 4-drug Regimen Treat 6 months or longer Single drug=resistance Adding single drug to failing regimen can lead to additional resistance!!!!! 2

3 Treatment failure Relapse Ongoing transmission; and Development of drug resistance 4 basic treatment regimens recommended for adults with TB disease Known drug susceptible to 4 initial drugs Each regimen consists of initial 2- months phase followed by a continuation phase of 4-7 months 3

4 Crucial for preventing the emergence of drug resistance and determining the ultimate outcome of the regimen! All 4 drugs should be included in initial phase INH and RIF- allow for short-course regiments with high cure rates PZA- potent sterilizing activity allowing for further shortening of the regimen from 9 to 6 months EMB- helps to prevent emergence of RIF resistance when primary INH resistance is present (if drug-susceptibilities are known, EMB need not be included if EMB sensitive) Regimen 1 INH, RIF, PZA and EMB 7days/week for 56 doses (8weeks) Or 5 days/week for 40 doses (8weeks) 4

5 Regimen 2 7days/week for 14 doses (2weeks) Then, 2 days/week for 12 doses (6 weeks) Or 5 days/week for 10 doses (2 weeks) Then, 2 days/week for 12 doses (6weeks) (doses less than 7 days a week should be DOT) Regimen 3 3 times weekly for 24 doses (8weeks) 5

6 Regimen 4 o 7day/week for 56 doses (8weeks) Or o 5 days/week for 40 doses (8weeks) (via DOT) Treatment for 4-7 months 4 months only for uncomplicated, non-cavitary, drugsusceptible TB and only if there is documented sputum culture conversion within the first 2 months 7 months for patients with the following: Cavitary or extensive pulmonary TB caused by drugsusceptible organisms and sputum culture obtained at time of completion of 2 months of treatment is positive Initial phase did not include PZA Treated with once-weekly INH and RPT, whose sputum culture at time of completion of initial phase(i.e., after 2 months) is positive 6

7 Regimen 1 1a INH and RIF 7 days/week for 126 doses (18 weeks) or 5 days/week for 90 doses (18 weeks) 1b INH and RIF 2days/week for 36 doses (18 weeks) 1c INH/RPT 1 day/week for 18 doses (18 weeks) (HIV neg, neg smears at 2 months of therapy, no cavitation on initial CXR, extend treatment 3 months if culture + after 2 months) Regimen 2 2a INH and RIF 2days/week for 36 doses (18 weeks) 2b INH /RPT 1day/week for 18 doses (18 weeks) (HIV neg, neg smears at 2 months of therapy, no cavitation on initial CXR, extend treatment 3 months if culture + after 2 months) 7

8 Regimen 3 3a INH/RIF 3 times weekly for 54 doses (18weeks) Regimen 4 4a INH/RFT 7 days/week for 217 doses (31 weeks) or 5 days/week for 155 doses (31 weeks) 4b INH/RIF Twice weekly for 62 doses (31 weeks) 8

9 Patients on regimens given less than 7 days a week should receive DOT Regimens given less than 3 times a week are NOT recommended for HIV-infected patients with CD4+ counts less than 100 Although basic TB regimens are broadly applicable, there are modifications that should be made under special circumstances (e.g., HIV infection, drug resistance, pregnancy, or treatment of children). Total number of doses prescribed within the specified time frame Duration of therapy depends on the drugs used, the drug susceptibility test results of the isolate, and the patient s response to therapy Goal is to complete all doses within 1 year. 9

10 32 y/o female HIV Positive CD 4 count- 89 CXR- RUL cavitary lesion Smear and culture positive for MTB. Initial Phase 4 drugs Daily for 56 doses (8 weeks) Drug susceptible DC EMB DC PZA after 56 doses 10

11 INH and Rifampin Daily 7x week for 217 doses (31 weeks) Consider changing to 3x week once CD 4 count above 100+ to complete 39 weeks 24 y/o female HIV negative CXR- bilateral infiltrates Smear and culture positive 11

12 Initial Phase 4 drugs Regimen #1= daily for 8 weeks (7 or 5 day) 14 doses for 2 weeks (DOT), or 10 doses 5 days/week then 2x week for 6 weeks (12 doses) After 2 weeks patient develops rash and itching. Drug challenge Found to be PZA PZA is Discontinued 12

13 Finish out Initial phase with 3 drugs Find she is drug Susceptible DC EMB Sputum converted within 2 months. What drugs would you use? INH/RIF How Long would you treat? 9 months Why? Unable to use PZA in initial phase. 13

14 32 Y/O Male HIV negative Uncontrolled Diabetic CXR- right pleural effusion Smear positive and culture positive on pleural biopsy Initial Phase 4 drugs- Daily for 8 weeks most physicians will chose to do dailies during the initial phase on an uncontrolled diabetic. Drug Susceptibilities-sensitive to all 4 EMB Discontinued Pulmonary sputa returning smear and culture negative 14

15 PZA discontinued after 8 weeks INH/RIF Which Regimen? 3 times weekly for 54 doses (18 weeks), or 2 times weekly for 36 doses (18 weeks) How Long? Total of 26 weeks may need to extend depending on patients improvement, and DM, WHY? Diabetics have a lowered immune system in general and take longer to convert sputa in pulmonary MTB, have increased risk for relapse During Initial Phase > 14 days- restart treatment from beginning < 14 days- continue treatment to complete planned total number of doses ( complete within 3 months) 15

16 During Continuation Phase > 80% of doses, and sputum was AFB smear negative on initial testing- further therapy may not be necessary > 80% of doses, sputum was AFB smear positive on initial testing- continue therapy until all doses completed < 80 % of doses, and lapse is less than 3 months in duration- continue until all doses are completed (full course); or < 80% of doses, and lapse is greater than 3 months in duration- restart therapy form the beginning of initial phase. Get a consult Get extended panel Molecular testing Daily DOT Failure to convert sputum cultures to negative after 4 months= treatment failure Augment regimen with 2 or 3 new drugs Drug levels 16

17 1) Initial phase should consist of 4 drugs? True 2) The continuation phase consists of 6 months? False 3) If there is not documented sputum conversion within the first 2 months of therapy the 4 month continuation phase is enough? False 4) If a patient received PZA in the initial phase the 4 month continuation phase is plenty? True 5) DOT is not necessary on patients who receive medication less than 7 days a week? False 6) It is okay to give 2x a week medication to an HIV infected individual with a CD 4 count less than 100? False 7) PZA is discontinued once drug susceptibilities are known? False 1) The goal to complete all doses of TB treatment is within 1 year? True 17

Dose Counting Exercise Elizabeth Foy, RN, BSN September 8, 2016

Dose Counting Exercise Elizabeth Foy, RN, BSN September 8, 2016 Dose Counting Exercise Elizabeth Foy, RN, BSN September 8, 2016 TB Nurse Case Management September 7-9, 2016 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Jessica Quintero, M.Ed., has the following disclosures

More information

Treatment of Tuberculosis, 2017

Treatment of Tuberculosis, 2017 Treatment of Tuberculosis, 2017 Charles L. Daley, MD National Jewish Health University of Colorado Health Sciences Center Treatment of Tuberculosis Disclosures Advisory Board Horizon, Johnson and Johnson,

More information

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 LTBI and TB Disease Treatment Cara Christ, MD, MS May 8, 2012 Cara Christ, MD, MS has the following disclosures to make: No conflict

More information

Managing the Patients Response to TB Treatment

Managing the Patients Response to TB Treatment Managing the Patients Response to TB Treatment Barbarah Martinez, RN, BSN September 13, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Barbarah Martinez, RN, BSN has

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

Treatment of Tuberculosis

Treatment of Tuberculosis TB Clinical i l Intensive Seattle Treatment of Tuberculosis June 16, 2016 Masa Narita, MD Public Health Seattle & King County; Firland Northwest TB Center, University of Washington Outline Unique features

More information

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures

More information

Treatment of Active Tuberculosis

Treatment of Active Tuberculosis Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest

More information

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case

More information

Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation

Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation Therapeutic Drug Monitoring for Improving TB Treatment Outcomes: A Concept for a Randomized Clinical Trial before Clinical Implementation Randall Reves, MD, MSc TB Consultant Professor of Medicine and

More information

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI: Pre-Treatment Evaluation Before initiating treatment for LTBI: Treatment of Latent TB Infection (LTBI) Amee Patrawalla, MD Associate Professor, New Jersey Medical School Attending Physician, NJMS Global

More information

Utilizing All the Tools in the TB Toolbox

Utilizing All the Tools in the TB Toolbox Utilizing All the Tools in the TB Toolbox Sandra Morano, B.A., R.N. Public Health Nurse, City of Stamford, CT TB Talk The New England TB Consortium March 18, 2010 Background TB Program, City of Stamford,

More information

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Managing Complex TB Cases Diana M. Nilsen, MD, RN Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private

More information

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD Patient History 1 The Role of Surgery in the Management of TB Reynard McDonald, MD & Paul Bolanowski, MD September 16, 2010 42 y/o AA male was initially diagnosed with pansensitive pulmonary TB in 1986

More information

has the following disclosures to make:

has the following disclosures to make: CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash

More information

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.

More information

Treatment of Tuberculosis

Treatment of Tuberculosis Treatment of Tuberculosis Marcos Burgos, MD April 5, 2016 TB Intensive April 5 8, 2016 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Marcos Burgos, MD has the following disclosures to make: No conflict

More information

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012 TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release

More information

Treatment of Latent TB Infection (LTBI)

Treatment of Latent TB Infection (LTBI) Treatment of Latent TB Infection (LTBI) Mahesh C. Patel, MD June 14, 2017 2014 MFMER slide-1 Mahesh C. Patel, MD Associate Professor Treatment of LTBI Department of Internal Medicine, Division of Infectious

More information

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population

More information

TB Update: March 2012

TB Update: March 2012 TB Update: March 2012 David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Public Health 1 TB Update: March 2012 IGRAs vs TST LTBI A New Regimen NAATs What is Their

More information

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control

More information

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB and Comorbidities Adriana Vasquez, MD April 12, 2018 TB Nurse Case Management April 10 12, 2018 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Adriana Vasquez, MD has the following disclosures to make:

More information

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015 Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

TB Intensive San Antonio, Texas

TB Intensive San Antonio, Texas TB Intensive San Antonio, Texas April 6-8, 2011 TB Disease: ATS/CDC/IDSA Guidelines Barbara Seaworth, MD Thursday April 7, 2011 Barbara Seaworth, MD has the following disclosures to make: Has received

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 7 References Related ACA Standards 4 th Edition Standards for Adult Correctional Institutions 4-4350, 4-4355 These guidelines are based on the recommendations of the American Thoracic Society

More information

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH V. TB and HIV/AIDS A. Standards of Treatment and Management The majority of TB treatment principles apply to persons with HIV/AIDS who require treatment for TB disease. The following points are either

More information

6/8/2018 TB TREATMENT. Bijan Ghassemieh, MD Seattle TB Clinical Intensive Disclosures. None

6/8/2018 TB TREATMENT. Bijan Ghassemieh, MD Seattle TB Clinical Intensive Disclosures. None TB TREATMENT Bijan Ghassemieh, MD Seattle TB Clinical Intensive 2018 Disclosures None 1 Objectives Understand the following Rationale and goals for standard TB regimen When to initiate TB treatment Standard

More information

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis? Tuberculosis Understanding, Investigating, Eliminating Jeff Maupin, RN Tuberculosis Control Nurse Sedgwick County Division of Health Objectives At the conclusion of this presentation, you will be able

More information

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015 Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian

More information

Pediatric TB Intensive Houston, Texas October 14, 2013

Pediatric TB Intensive Houston, Texas October 14, 2013 Pediatric TB Intensive Houston, Texas October 14, 2013 Diagnosis and Management of Tuberculosis in Adolescents Andrea T. Cruz, MD, MPH Sections of Infectious Diseases & Emergency Medicine October 14, 2013

More information

Treatment of Tuberculosis

Treatment of Tuberculosis Treatment of Tuberculosis, 1940 s Treatment of Tuberculosis ATS/CDC/IDSA Joint Statement 2003 Saskatchewan Lung Association Outline, 2012 Treatment of Tuberculosis Principles of treatment of tuberculosis

More information

Tuberculosis Intensive November 17 20, 2015 San Antonio, TX

Tuberculosis Intensive November 17 20, 2015 San Antonio, TX Treatment of Tuberculosis Elizabeth S. Guy, MD November 17, 2015 Tuberculosis Intensive November 17 20, 2015 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Elizabeth S. Guy, MD has the following disclosures

More information

When Can Isolation Be Discontinued?

When Can Isolation Be Discontinued? When Can Isolation Be Discontinued? - It Depends on the Patient and the Setting. Masae Kawamura M.D. and Barbara Seaworth M.D. Texas: (800) TEX-LUNG New Jersey: 973-972-3270? HNTC Consultation Line California:

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015 Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015 Initiation Phase Part 1 Ginny Dowell, RN, BSN February 4, 2015 Ginny Dowell RN, BSN has the following disclosures to make:

More information

Case Management of the TB/HIV Infected Patient

Case Management of the TB/HIV Infected Patient TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Case Management of the TB/HIV Infected Patient Sarah Hoffman, MPH, MSN, ACRN December 9, 2009 TB/HIV: Considerations in the Care of the Coinfected

More information

Treatment of Tuberculosis

Treatment of Tuberculosis TB Intensive Tyler, Texas June 1-3, 2009 Treatment of Tuberculosis Barbara Seaworth, MD June 3, 2009 Treatment of Tuberculosis Barbara J Seaworth MD Medical Director Heartland National TB Center 1 Purpose

More information

Errors in Dx and Rx of TB

Errors in Dx and Rx of TB Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a

More information

TB in the Correctional Setting Florence, Arizona October 7, 2014

TB in the Correctional Setting Florence, Arizona October 7, 2014 TB in the Correctional Setting Florence, Arizona October 7, 2014 Diagnosis and Treatment of TB Disease Renuka Khurana, MBBS, MPH October 7, 2014 Renuka Khurana, MSSB, MPH has the following disclosures

More information

Contact Investigation

Contact Investigation Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period

More information

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 TUBERCULOSIS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY GLOBAL EMERGENCY: * Tuberculosis kills 5,000 people a day! * 2.3 million die each year!

More information

Role of Surgery in the Management of TB. Lee Reichman, MD & Paul Bolanowski, MD

Role of Surgery in the Management of TB. Lee Reichman, MD & Paul Bolanowski, MD Role of Surgery in the Management of TB Lee Reichman, MD & Paul Bolanowski, MD Patient Background Patient is a 19 year old Bolivian female who immigrated to the US in February 2002 On 3/20/02, she presenting

More information

Patient Background. Role of Surgery in the Management of TB. Patient Background CXR 3/20/02

Patient Background. Role of Surgery in the Management of TB. Patient Background CXR 3/20/02 Patient Background Role of Surgery in the Management of TB Patient is a 19 year old Bolivian female who immigrated to the US in February 2002 On 3/20/02, she presenting to a hospital with complaints of

More information

TB Contact Investigation

TB Contact Investigation Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.

More information

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:

More information

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009 TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages

More information

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has

More information

At the end of this session, participants will be able to:

At the end of this session, participants will be able to: Advanced Concepts in Pediatric Tuberculosis: Infection Control, Source Case and Contact Investigation Ana M. Alvarez, M.D. Associate Professor Division of Pediatric Infectious Diseases and Immunology University

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18 Screening, Diagnosis, and Treatment of TB in Persons with Diabetes Dean Schillinger, M.D. University of California San Francisco CA Diabetes Program Gisela Schecter, M.D., M.P.H. TB Control Branch CA Department

More information

Tuberculosis Intensive

Tuberculosis Intensive Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

TUBERCULOSIS. Pathogenesis and Transmission

TUBERCULOSIS. Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are

More information

TB Intensive San Antonio, Texas December 1-3, 2010

TB Intensive San Antonio, Texas December 1-3, 2010 TB Intensive San Antonio, Texas December 1-3, 2010 TB Case Presentations Doug Hornick, MD; Iowa U Medical School December 1, 2010 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD

More information

TB in the Patient with HIV

TB in the Patient with HIV TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to

More information

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female % San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population I. Demographic Information Table I-A: TB cases by gender, SJC, 03 (N=43) GENDER NUMBER OF CASES Male 6 60.5% Female 7

More information

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease Barbara J Seaworth MD Medical Director Heartland National TB Center Professor of Medicine University of Texas Health Center Tyler Barbara J Seaworth MD has

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Rehuka Khurana, MD, MPH has the following disclosures to make:

Rehuka Khurana, MD, MPH has the following disclosures to make: Case Presentation Steps to a Systematic Approach to Diagnosis of TB Case Presentation Steps to a Systematic Approach to Diagnosis of TB Renuka Khurana, MD, MPH March 13, 2015 TB for Pulmonologist March

More information

Treatment of Tuberculosis Disease. Treatment of Tuberculosis. Decision to Treat Initiation of Therapy 1

Treatment of Tuberculosis Disease. Treatment of Tuberculosis. Decision to Treat Initiation of Therapy 1 Treatment of Tuberculosis Some Highlights of Most Recent Update Treatment of Tuberculosis Disease Germaine Jacquette, MD Physician Specialist NJMS Global Tuberculosis Institute September 15, 2010 The provider

More information

Treatment of Tuberculosis

Treatment of Tuberculosis Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society of America Please note: An erratum has been published for this article. To view the erratum, please click here.

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant

More information

Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make:

Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make: INFECTION CONTROL PRACTICES Rebecca O. Sanchez, RN, BSN, MPH Texas Department of State Health Services Texas Center for Infectious Disease Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures

More information

TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012

TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012 TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012 Challenges of TB Treatment in Special Populations in Corrections Marcos Burgos, MD November 28, 2012 Marcos Burgos, MD has the following

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

TB in Corrections Phoenix, Arizona

TB in Corrections Phoenix, Arizona TB in Corrections Phoenix, Arizona March 24, 2011 Contact Investigation in the Correctional Setting Jessica Quintero, BAAS March 24, 2011 Jessica Quintero, BAAS has the following disclosures to make: No

More information

Preventing TB: Recent Research Results and Novel Short Course Therapy for LTBI

Preventing TB: Recent Research Results and Novel Short Course Therapy for LTBI Preventing TB: Recent Research Results and Novel Short Course Therapy for LTBI Constance A. Benson, M.D. Professor of Medicine Director, UCSD AntiViral Research Unit PI, CD4 Collaborative HIV Clinical

More information

Disclosures. Outline. No disclosures or conflicts of interest to report. Special LTBI situations. H t it d id ff t

Disclosures. Outline. No disclosures or conflicts of interest to report. Special LTBI situations. H t it d id ff t Selected Topics in LTBI June 2, 2015 Bijan Ghassemieh, MD Senior Fellow UW Division of Pulmonary/Critical Care Disclosures No disclosures or conflicts of interest to report Outline Special LTBI situations

More information

Anti Tuberculosis Medications: Side Effects & adverse Events

Anti Tuberculosis Medications: Side Effects & adverse Events Anti Tuberculosis Medications: Side Effects & adverse Events Diana Fortune, RN, BSN September 13, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Diana Fortune, RN,

More information

Short Course Treatment for MDR TB

Short Course Treatment for MDR TB Objectives Short Course Treatment for MDR TB Barbara J Seaworth M.D. Medical Director Heartland National TB Center Professor of Medicine, University of Texas Health Northeast Participants will utilize

More information

Tuberculosis: update 2013

Tuberculosis: update 2013 Tuberculosis: update 2013 William R. Bishai, MD, PhD Center for TB Research Division of Infectious Diseases Department of Medicine Johns Hopkins School of Medicine Question 1 A TB speaker at a major conference

More information

Treatment of Tuberculosis

Treatment of Tuberculosis Recommendations and Reports June 20, 2003 / 52(RR11);1-77 Recommendations and Reports June 20, 2003 / 52(RR11);1-77 Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society

More information

Standard TB Treatment

Standard TB Treatment Standard TB Treatment Chris Keh, MD TB Controller, TB Prevention and Control Program, San Francisco Department of Public Health Assistant Clinical Professor, Division of Infectious Diseases, University

More information

TB Intensive Tyler, Texas December 2-4, 2008

TB Intensive Tyler, Texas December 2-4, 2008 TB Intensive Tyler, Texas December 2-4, 2008 TB Case Presentations Douglas B. Hornick, MD December 3, 2008 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD Professor University of

More information

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders Maryland TB Program Evaluation Sputum Culture Conversion TB Program Managers Workshop February 22, 2011 CDC Framework for Program Evaluation Maryland Evaluation Team Cathy Goldsborough, RN, Former Nurse

More information

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014 Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB

More information

TB Program Management San Antonio, Texas November 5-7, 2008

TB Program Management San Antonio, Texas November 5-7, 2008 TB Program Management San Antonio, Texas November 5-7, 2008 Infection Control Lynelle Phillips, RN, MPH November 7, 2008 Infection Control Lynelle Phillips, RN MPH Nurse Consultant Heartland National TB

More information

My heart is racing. Managing Complex Cases. Case 1. Case 1

My heart is racing. Managing Complex Cases. Case 1. Case 1 Managing Complex Cases My heart is racing Amee Patrawalla, MD April 7, 2017 Case 1 Rutgers, The State University of New Jersey Rutgers, The State University of New Jersey Case 1 29 year old physician from

More information

Tuberculosis Update. Objectives. Introduction. Tuberculosis Update Eric J. Bihler, DO

Tuberculosis Update. Objectives. Introduction. Tuberculosis Update Eric J. Bihler, DO Tuberculosis Update Eric Bihler Objectives Brief overview of epidemiology and transmission Differentiate between latent and active tuberculosis Treatment of tuberculosis Common side effects of therapy

More information

Contact Investigation and Prevention in the USA

Contact Investigation and Prevention in the USA Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254) Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)-750-5496 Local health care providers, including physicians offices, labs and hospitals, are required by law to

More information

TBTC research update: are we ready for 3 month treatment? 2009 TBTC Recompetition. NTCA presentation outline

TBTC research update: are we ready for 3 month treatment? 2009 TBTC Recompetition. NTCA presentation outline TBTC research update: are we ready for 3 month treatment? Stefan Goldberg, MD Project officer, TBTC Studies 27, 28, 29 Tuberculosis Trials Consortium (TBTC) CDC Division of TB Elimination NTCA breakout

More information

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 TB Case Presentation Andrea Cruz, MD, MPH August 14, 2014 Andrea Cruz, MD, MPH has the following disclosures to

More information

TB Intensive San Antonio, Texas August 7-10, 2012

TB Intensive San Antonio, Texas August 7-10, 2012 TB Intensive San Antonio, Texas August 7-10, 2012 An Introduction to Childhood Tuberculosis Kim Smith, MD, MPH August 10, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests

More information

Management of MDR TB in special situations. Dr Sarabjit Chadha The Union

Management of MDR TB in special situations. Dr Sarabjit Chadha The Union Management of MDR TB in special situations Dr Sarabjit Chadha The Union MDR TB in special situations Pregnancy Breastfeeding Contraception Renal Insufficiency Diabetes Pregnancy and TB Pregnancy is not

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

TB Contact Investigation Basics

TB Contact Investigation Basics TB Nurse Case Management Lisle, Illinois April 27-28, 28 2010 TB Contact Investigation Basics Carrie Storrs, RN April 28, 2010 Contact Investigation Carrie Storrs TB Program Illinois Department of Public

More information

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Co-morbidities in Substance Abuse that Impact Managing TB Lisa Armitige, MD, PhD April 27, 2011 Lisa Armitige, MD, PhD has the following

More information

TB Intensive San Antonio, Texas May 7-10, 2013

TB Intensive San Antonio, Texas May 7-10, 2013 TB Intensive San Antonio, Texas May 7-10, 2013 TB in the HIV Patient Lisa Armitige, MD, PhD May 09, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests No relevant

More information

Tuberculosis: A Provider s Guide to

Tuberculosis: A Provider s Guide to Tuberculosis: A Provider s Guide to Diagnosis and Treatment of Active Tuberculosis (TB) Disease and Screening and Treatment of Latent Tuberculosis Infection (LTBI) Alameda County Health Care Services Agency

More information

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System

More information

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014 What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks

More information

Case Study: TB-HIV co-infection

Case Study: TB-HIV co-infection Case Study: TB-HIV co-infection Julia Greenleaf, RN, MPH Public Health Nurse Public Health Madison & Dane County With guest appearance by Julie Tans-Kersten, MS, BSMT (ASCP) Director, WI TB Program 33

More information

TB Intensive San Antonio, Texas

TB Intensive San Antonio, Texas TB Intensive San Antonio, Texas August 2-5, 2011 Pediatric TB Jeffrey Starke, MD August 5, 2011 Jeffrey Starke, MD has the following disclosures to make: Is on a data safety monitoring board for Hoffman

More information

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 TB and Diabetes Barbara Seaworth, MD November 13, 2014 Barbara Seaworth, MD has the following disclosures to make: No conflict of interests No relevant

More information